Compagnie Lombard Odier S Cm A Repare Therapeutics Inc. Transaction History
Compagnie Lombard Odier S Cm A
- $6.42 Billion
- Q4 2024
A detailed history of Compagnie Lombard Odier S Cm A transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 14,000 shares of RPTX stock, worth $17,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,000
Previous 14,000
-0.0%
Holding current value
$17,500
Previous $48,000
62.5%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RPTX
# of Institutions
59Shares Held
33.6MCall Options Held
51KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$12.9 Million0.51% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$4.3 Million1.93% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$4.15 Million0.12% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$3.71 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.31 Million5.13% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $52.4M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...